Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs
Back to article page
Feature Article|Updated:2021-08-23
|
Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs
Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs
Chinese Journal of Integrative Medicine2020年26卷第4期 页码:251-255
Affiliations:
1.Holistic Integrative Pharmacy Institutes and Comprehensive Cancer Diagnosis and Treatment Center, the Affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University, Hangzhou (311121), China
2.Key Laboratory of Elemene Class Anti-cancer Chinese Medicine of Zhejiang Province and Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Hangzhou Normal University, Hangzhou (311121), China
Author bio:
Correspondence to: Prof. XIE Tian, E-mail:drxiet@aliyun.com
Funds:
the National Natural Science Foundation of China(81672932;81730108;81874380;81973635);Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars(LR18H160001);Zhejiang Province Science and Technology Project of TCM(2019ZZ016);Zhejiang Province Medical Science and Technology Project(2017RC007);Talent Project of Zhejiang Association for Science and Technology(2017YCGC002);Key Project of Hangzhou Ministry of Science and Technology(20162013A07)
Xin-bing SUI, Tian XIE. Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs[J]. Chinese Journal of Integrative Medicine, 2020,26(4):251-255.
Xin-bing SUI, Tian XIE. Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs[J]. Chinese Journal of Integrative Medicine, 2020,26(4):251-255.
Xin-bing SUI, Tian XIE. Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs[J]. Chinese Journal of Integrative Medicine, 2020,26(4):251-255. DOI: 10.1007/s11655-019-3180-x.
Xin-bing SUI, Tian XIE. Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs[J]. Chinese Journal of Integrative Medicine, 2020,26(4):251-255. DOI: 10.1007/s11655-019-3180-x.
Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs
摘要
Abstract
Resistance to anticancer drugs is a major problem in oncology
which causes the failure of antitumor treatment. A variety of factors contribute to drug resistance
including drug efflux and metabolism
tumor cell heterogeneity
tumor microenvironment stress-induced genetic or epigenetic alterations in the cancer cells and so on. However
how to circumvent this resistance to improve anticancer efficacy remains to be determined. To circumvent chemotherapeutic resistance
many reversal agents have been developed
but most of them fail in clinical trials due to severe adverse effects. Recently
several natural products have been reported to augment sensitivity or overcome resistance of anticancer chemotherapeutic drugs
including elemene
curcumin
Shenqi Fuzheng Injection (参芪扶正注射液)
PHY906
etc. Thus
understanding the novel function of Chinese medicine may allow us to develop a promising therapeutic approach to enhance the effects of anticancer strategies and prevent or overcome their resistance in the treatment of cancer patients.
关键词
Keywords
Chinese medicineWestern medicineintegrative Chinese and Western medicineresistanceanticancer drugs
Treatment Progress in Diminished Ovarian Reserve: Western and Chinese Medicine
Which Is Safer, Chinese Medicine or Western Medicine?Comparative Analysis Based on Chinese Spontaneous Reporting Database
Progress in Treatment of Gout Using Chinese and Western Medicine
New Concept of Health with Perspective of Chinese Medicine
相关作者
暂无数据
相关机构
Department of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital
Department of Encephalopathy, Shaanxi Provincial Hospital of Chinese Medicine
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University
Key Laboratory of Elemene Class Anti-cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University